Iontophoresis
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| This article may require cleanup to meet Wikipedia's quality standards. Please improve this article if you can. |
Iontophoresis is a non-invasive method of propelling high concentrations of a charged substance, normally medication or bioactive-agents, transdermally by repulsive electromotive force using a small electrical charge applied to an iontophoretic chamber containing a similarly charged active agent and its vehicle. To clarify, one or two chambers are filled with a solution containing an active ingredient and its solvent, termed the vehicle. The positively charged chamber, termed the cathode will repel a positively charged chemical, whilst the negatively charged chamber, termed the anode, will repel a negatively charged chemical into the skin.
Iontophoresis is well classified for use in transdermal drug delivery. Unlike transdermal patches, this method relies on active transportation within an electric field. In the presence of an electric field electromigration and electroosmosis are the dominant forces in mass transport. These movements are measured in units of chemical flux, commonly µmol/cm2h. For more information see Fick's Law of Diffusion.
Mechanism
There are a number of factors that influence iontophoretic transport including skin pH, drug concentration and characteristics, ionic competition, molecular size, current, voltage, time applied and skin resistance. The current density of the treatment electrode is perhaps the most important variable relative to the degree of ion transfer. Studies suggest that comparable iontophoretic doses delivered at low currents over longer periods are more effective than those delivered by high currents over a short periods (Anderson et al, 2003).
The isoelectric point of the skin is ~4; therefore, under physiological conditions, with the surface of the skin also buffered at or near 7.4, the membrane has a net negative charge and electroosmotic flow is from anode (-) to cathode (+). The phenomenon of electroosmosis has been used as a means to augment the anodic delivery of (in particular) large, positively charged drugs, the transport numbers of which are often extremely small (and whose iontophoretic enhancement therefore depends heavily upon electroosmosis) and to promote the transdermal migration of uncharged, yet polar, molecules, the passive permeation of which is typically very small.
The application of a charge to the skin alters the skin’s permeability increasing migration of the active ingredient into the epidermis. There are a number of pathways that the ingredients could take, but research suggests that the majority of drugs permeate the skin via appendageal pores, including hair follicles and sweat glands, although some delivery is via the paracellular channels and minimal quantities are transcellular.
Transport of lipophilic drug molecules is believed to be facilitated by its dissolution into the lipid matrix of the stratum corneum however hydrophilic drugs which are thought to permeate through the open pores or cutaneous appendages (hair follicle and sebaceous glands) only accounts for 0.1% of the total skin surface area.[1]
Uses
Reverse iontophoresis is the term used to describe the process whereby molecules are removed from within the body for detection. In reverse iontophoresis the negative charge of the skin at buffered pH causes it to be permselective to cations causing solvent flow towards the anode. This flow is the dominant force allowing movement of neutral molecules, including glucose, across the skin. This technology is currently being used in such devices as the GlucoWatch which allows for blood glucose detection across skin layers using reverse iontophoresis.
Iontophoresis is commonly used by physical therapists for the application of anti-inflammatory medications. Common diagnoses treated with Iontophoresis include plantar fasciitis, bursitis and hyperhidrosis. Iontophoresis of Acetylcholine is used in research as a way to test the health of the endothelium by stimulating endothelium dependent generation of nitric oxide and subsequent microvascular vasodilation. Acetylcholine is positively charged and therefore placed in the anode.
Tap Water Iontophoresis for Hyperhidrosis
Disclosure - though section was written by a company providing iontophoresis machines, the information is factual and informative.
Hyperhidrosis (excessive sweating) of the hands, feet and axilla can be treated using tap water iontophoresis. It is recommended that a full and detailed assessment by a qualified specialist dermatologist is performed prior to engaging in treatment of hyperhidrosis; predominantly to exclude treatable underlying medical disorders. The extremities to be treated are placed in shallow water baths and a low voltage circuit is created using a specialised machine. The current is turned up until there is a tingling sensation on the skin. The treatment lasts for 10-15 mins and then the current is reversed for another 10-15 minutes. The initial treatment phase is for 7 sessions in first month. The treatment is usually effective in over 85% of patients using tap water. After the initial treatment phase it is recommended that maintenance treatments are carried out as soon as sweating starts again. No one is quite sure how the treatment works but it is effective non invasive treatment for excessive sweating of the hands feet and armpits.[1] [1]
See also
External links
References
de:Iontophorese nl:Iontoforese
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

